中山地区早产儿出院时宫外生长迟缓调查

来源 :中国妇幼保健 | 被引量 : 0次 | 上传用户:metoo321
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:评价早产儿出生时宫内生长受限(IUGR)和出院时宫外生长迟缓(EUGR)的发生情况。方法:以中山市博爱医院新生儿科2009年1月~2012年5月出生的早产儿为研究对象,分别以出生时、出院时生长发育指标在相应宫内生长速率期望值的第10百分位水平以下定义为IUGR、EUGR,分别计算各胎龄组及体重组IUGR、EUGR发生率及总的发生率,并计算各胎龄组及各体重组EUGR发生率比IUGR发生率增加的比例。结果:1 954例早产儿,IUGR与EUGR发生率以体重评价分别为10.64%和29.32%,以身长评价分别为10.18%和20.83%,以头围评价分别为5.63%和13.46%。其中极低出生体重儿占14.99%,发生体重、身长和头围EUGR者分别为51.54%,47.10%和29.69%。不同出生胎龄(<28周、28~32周、32~35周、≥35周)出院时EUGR发生率较出生时IUGR发生率变化的情况:以头围为指标的≤P10、≤P3和以身长为指标≤P3的EUGR较IUGR增加率呈倒“U”型趋势,组间差异有统计学意义(P<0.05)。不同出生体重组(<1 500 g、1 500~2 500 g、≥2 500 g)以体重、身长、头围为指标EUGR较IUGR的发生率增加的比例均随出生体重的降低而升高,各组以体重为指标,EUGR发生率分别增加25.60%、21.28%、1.55%;以身长为指标,EUGR发生率分别增加16.72%、11.43%、1.86%;以头围为指标,EUGR发生率分别增加10.92%、8.74%、1.24%,组间比较差异有统计学意义(P<0.001)。结论:早产儿IUGR发生率较高,出院时EUGR发生率较IUGR发生率增高,且出院时EUGR发生率较出生时IUGR发生率的增加随出生体重的降低而升高。 PURPOSE: To evaluate the incidence of intrauterine growth restriction (IUGR) at birth and the extrauterine growth retardation (EUGR) at discharge in preterm infants. Methods: The preterm infants born from January 2009 to May 2012 in Bo’ai Hospital of Zhongshan City were studied. The indexes of growth and development at birth and discharge were respectively calculated at the 10th percentile of the expected intrauterine growth rate The following definitions were defined as IUGR and EUGR. The incidences of IUGR and EUGR in each gestational age group and body weight group and the overall incidence were calculated, and the incidence of EUGR was higher than that of IUGR in each gestational age group and each group. Results: The prevalence rates of IUGR and EUGR in 1 954 premature infants were 10.64% and 29.32% respectively, with body length of 10.18% and 20.83%, respectively, and the head circumference was 5.63% and 13.46% respectively. Among them, very low birth weight accounted for 14.99%, weight, length and head circumference of EUGR were 51.54%, 47.10% and 29.69% respectively. The difference in the incidence of EUGR at birth from birth at birth at different gestational ages (<28 weeks, 28-32 weeks, 32-35 weeks, ≥35 weeks) was significantly related to the incidence of IUGR at birth: ≤10, ≤3 and The growth rate of EUGR in EUGR with the length of ≤3 was higher than that of IUGR, and there was a significant difference between the two groups (P <0.05). The proportion of EUGR to IUGR in different birth weight groups (<1 500 g, 1 500 ~ 2 500 g, ≥2 500 g) increased with the decrease of birth weight with weight, length and head circumference as indexes. The incidence of EUGR increased by 25.60%, 21.28% and 1.55%, respectively, in each group with body weight. The incidence of EUGR increased by 16.72%, 11.43% and 1.86% respectively with the body length as the index. The incidence of EUGR was Increased by 10.92%, 8.74%, 1.24%, the difference between the two groups was statistically significant (P <0.001). Conclusion: The incidence of IUGR in preterm infants is higher than that of IUGR at discharge. The incidence of EUGR at discharge is higher than that at birth.
其他文献
目的探讨腹针联合玻璃酸钠关节腔注射治疗膝关节骨关节炎的临床疗效。方法120例膝骨关节炎患者采用投币法分为观察组(60例)和对照组(60例),观察组采取腹针联合玻璃酸钠关节腔注射疗法,腹针,1次/d,5次为1个疗程,间歇2 d,再做第2个疗程,共4个疗程(4周);同期玻璃酸钠注射液膝关节腔内注射,每次2 mL/20 mg,每周1次,共4周。对照组仅采取玻璃酸钠注射液膝关节腔内注射,每次2 mL/20
目的探讨原发性肝癌患者应用立体定向体部放射治疗的生物效应剂量。方法选择原发性肝癌患者80例,按照随机数字表法将患者分为观察组(40例)和对照组(40例)。患者均采用立体定向体部放疗治疗,观察组采用高分次剂量,对照组采用低分次剂量,比较两组不同剂量的放疗效果。结果观察组治疗后的有效率为77.5%,共有39例患者病情有变化,对照组有效率为55.0%,观察组的有效率明显高于对照组,差异有统计学意义(χ2